Lesuffleur T - Search Results

1

Expression of cytochrome P-450 3A in HT29-MTX cells and Caco-2 clone TC7.

Carrière V, Lesuffleur T, Barbat A, Rousset M, Dussaulx E, Costet P, de Waziers I, Beaune P, Zweibaum A. Carrière V, et al. Among authors: lesuffleur t. FEBS Lett. 1994 Dec 5;355(3):247-50. doi: 10.1016/0014-5793(94)01199-0. FEBS Lett. 1994. PMID: 7988682 Free article.

2

Adaptation to 5-fluorouracil of the heterogeneous human colon tumor cell line HT-29 results in the selection of cells committed to differentiation.

Lesuffleur T, Kornowski A, Luccioni C, Muleris M, Barbat A, Beaumatin J, Dussaulx E, Dutrillaux B, Zweibaum A. Lesuffleur T, et al. Int J Cancer. 1991 Nov 11;49(5):721-30. doi: 10.1002/ijc.2910490516. Int J Cancer. 1991. PMID: 1937958

3

Increased growth adaptability to 5-fluorouracil and methotrexate of HT-29 sub-populations selected for their commitment to differentiation.

Lesuffleur T, Kornowski A, Augeron C, Dussaulx E, Barbat A, Laboisse C, Zweibaum A. Lesuffleur T, et al. Int J Cancer. 1991 Nov 11;49(5):731-7. doi: 10.1002/ijc.2910490517. Int J Cancer. 1991. PMID: 1937959

4

Dihydrofolate reductase gene amplification-associated shift of differentiation in methotrexate-adapted HT-29 cells.

Lesuffleur T, Barbat A, Luccioni C, Beaumatin J, Clair M, Kornowski A, Dussaulx E, Dutrillaux B, Zweibaum A. Lesuffleur T, et al. J Cell Biol. 1991 Dec;115(5):1409-18. doi: 10.1083/jcb.115.5.1409. J Cell Biol. 1991. PMID: 1955481 Free PMC article.

5

Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells.

Lesuffleur T, Barbat A, Dussaulx E, Zweibaum A. Lesuffleur T, et al. Cancer Res. 1990 Oct 1;50(19):6334-43. Cancer Res. 1990. PMID: 2205381

6

Resistance of the human colon carcinoma cell line HCT-8 to methotrexate results in selection of cells with features of enterocytic differentiation.

Barbat A, Pandrea I, Cambier D, Zweibaum A, Lesuffleur T. Barbat A, et al. Among authors: lesuffleur t. Int J Cancer. 1998 Mar 2;75(5):731-7. doi: 10.1002/(sici)1097-0215(19980302)75:5<731::aid-ijc11>3.0.co;2-9. Int J Cancer. 1998. PMID: 9495241

7

Resistance to high concentrations of methotrexate and 5-fluorouracil of differentiated HT-29 colon-cancer cells is restricted to cells of enterocytic phenotype.

Lesuffleur T, Violette S, Vasile-Pandrea I, Dussaulx E, Barbat A, Muleris M, Zweibaum A. Lesuffleur T, et al. Int J Cancer. 1998 May 4;76(3):383-92. doi: 10.1002/(sici)1097-0215(19980504)76:3<383::aid-ijc16>3.0.co;2-c. Int J Cancer. 1998. PMID: 9579576

8

Postmitotic differentiation of colon carcinoma caco-2 cells does not prevent reentry in the cell cycle and tumorigenicity.

Pandrea IV, Carrière V, Barbat A, Cambier D, Dussaulx E, Lesuffleur T, Rousset M, Zweibaum A. Pandrea IV, et al. Among authors: lesuffleur t. Exp Mol Pathol. 2000 Aug;69(1):37-45. doi: 10.1006/exmp.2000.2309. Exp Mol Pathol. 2000. PMID: 10891291

9

Expression and characterization of mucins associated with the resistance to methotrexate of human colonic adenocarcinoma cell line HT29.

Dahiya R, Lesuffleur T, Kwak KS, Byrd JC, Barbat A, Zweibaum A, Kim YS. Dahiya R, et al. Among authors: lesuffleur t. Cancer Res. 1992 Sep 1;52(17):4655-62. Cancer Res. 1992. PMID: 1511431

10

Differential expression of the human mucin genes MUC1 to MUC5 in relation to growth and differentiation of different mucus-secreting HT-29 cell subpopulations.

Lesuffleur T, Porchet N, Aubert JP, Swallow D, Gum JR, Kim YS, Real FX, Zweibaum A. Lesuffleur T, et al. J Cell Sci. 1993 Nov;106 ( Pt 3):771-83. doi: 10.1242/jcs.106.3.771. J Cell Sci. 1993. PMID: 8308060

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters